Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
An Act to Implement the Provisions of the Hague Agreement and the Patent Law Treaty
| An Act to Implement the Provisions of the Hague Agreement and the Patent Law Treaty |
| Pubbl/distr/stampa | [Washington, D.C.] : , : [U. S. Government Printing Office], , [2012] |
| Descrizione fisica | 1 online resource (11 unnumbered pages) |
| Soggetto topico |
Design protection (International law)
Patents (International law) Patent laws and legislation - United States |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910704466003321 |
| [Washington, D.C.] : , : [U. S. Government Printing Office], , [2012] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
COVID-19-related vaccines and therapeutics : Preliminary insights on related patenting activity during the pandemic
| COVID-19-related vaccines and therapeutics : Preliminary insights on related patenting activity during the pandemic |
| Autore | Staff World Intellectual Property Organization |
| Pubbl/distr/stampa | Geneva : , : World Intellectual Property Organization, , 2022 |
| Descrizione fisica | 1 online resource (83 pages) |
| Soggetto topico |
COVID-19 (Disease)
Patents Patents (International law) |
| ISBN |
9789280533606
9789280533590 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- _Hlk93048502 -- Acknowledgements -- Key findings -- Introduction -- Background - biology of COVID-19 -- Overview of patenting activity related to COVID-19 -- Patent filings during 2020-2021 -- Filing and publication of COVID-19-related patent applications over time -- COVID-19-related vaccine and therapeutic patent applicant profiles -- Research collaboration and IP strategies related to technologies important to COVID-19 vaccines and therapeutics -- Disclosure of sequences within patent documents -- COVID-19 vaccines -- Background - vaccine platforms -- Conventional vaccine platforms -- Novel vaccine platforms -- Patent and vaccine distribution by vaccine platform and published applicant location -- Speed of vaccine development -- COVID-19 vaccine patent landscape -- Core vaccine technologies, collaboration and licensing -- Analysis of WHO data on COVID-19 vaccines -- Timelines on key technologies for COVID-19 vaccine development -- Technologies relevant to mRNA vaccine -- Timeline details for adenovirus vaccine development -- Timeline details for vaccine adjuvant development -- COVID-19 therapeutics -- Background -- Analysis of COVID-19 therapeutics-related patent applications by substances type -- Top locations of patent applicants for COVID-19 therapeutics and their filing strategies -- Highlights of patent filings related to COVID-19 therapeutic development -- Patent filings related to development of small-molecule drugs for COVID-19 -- Patent filings related to the development of biologics for COVID-19 -- Patents related to antibodies for COVID-19 treatment -- Peptide and protein therapies -- Nucleic-acid-based therapies -- Aptamer-mediated therapy -- Cell-based therapies -- Other biologic-based therapies -- Analysis of COVID-19 therapeutics in clinical trials.
Analysis of COVID-19 therapeutics data in the Milken Institute and Regulatory Affairs Professionals Society (RAPS) tracker data -- Distribution of COVID-19 drug candidates across small molecules and biologics, repurposed drugs and de novo synthesized drugs -- Classification of COVID-19 drug candidates in clinical trials by molecular nature and function -- Feature summary of examples of anti-COVID-19 drug candidates in clinical trials -- Perspectives -- Annex -- Data sources and methods -- Tables of vaccine types and candidates currently in clinical trials -- Examples of partial, early disclosure observed at the Israeli, U.K. and Singapore patent offices -- Glossary -- References -- Further reading. |
| Record Nr. | UNINA-9910796075603321 |
Staff World Intellectual Property Organization
|
||
| Geneva : , : World Intellectual Property Organization, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
COVID-19-related vaccines and therapeutics : Preliminary insights on related patenting activity during the pandemic
| COVID-19-related vaccines and therapeutics : Preliminary insights on related patenting activity during the pandemic |
| Autore | Staff World Intellectual Property Organization |
| Pubbl/distr/stampa | Geneva : , : World Intellectual Property Organization, , 2022 |
| Descrizione fisica | 1 online resource (83 pages) |
| Soggetto topico |
COVID-19 (Disease)
Patents Patents (International law) |
| ISBN |
9789280533606
9789280533590 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- _Hlk93048502 -- Acknowledgements -- Key findings -- Introduction -- Background - biology of COVID-19 -- Overview of patenting activity related to COVID-19 -- Patent filings during 2020-2021 -- Filing and publication of COVID-19-related patent applications over time -- COVID-19-related vaccine and therapeutic patent applicant profiles -- Research collaboration and IP strategies related to technologies important to COVID-19 vaccines and therapeutics -- Disclosure of sequences within patent documents -- COVID-19 vaccines -- Background - vaccine platforms -- Conventional vaccine platforms -- Novel vaccine platforms -- Patent and vaccine distribution by vaccine platform and published applicant location -- Speed of vaccine development -- COVID-19 vaccine patent landscape -- Core vaccine technologies, collaboration and licensing -- Analysis of WHO data on COVID-19 vaccines -- Timelines on key technologies for COVID-19 vaccine development -- Technologies relevant to mRNA vaccine -- Timeline details for adenovirus vaccine development -- Timeline details for vaccine adjuvant development -- COVID-19 therapeutics -- Background -- Analysis of COVID-19 therapeutics-related patent applications by substances type -- Top locations of patent applicants for COVID-19 therapeutics and their filing strategies -- Highlights of patent filings related to COVID-19 therapeutic development -- Patent filings related to development of small-molecule drugs for COVID-19 -- Patent filings related to the development of biologics for COVID-19 -- Patents related to antibodies for COVID-19 treatment -- Peptide and protein therapies -- Nucleic-acid-based therapies -- Aptamer-mediated therapy -- Cell-based therapies -- Other biologic-based therapies -- Analysis of COVID-19 therapeutics in clinical trials.
Analysis of COVID-19 therapeutics data in the Milken Institute and Regulatory Affairs Professionals Society (RAPS) tracker data -- Distribution of COVID-19 drug candidates across small molecules and biologics, repurposed drugs and de novo synthesized drugs -- Classification of COVID-19 drug candidates in clinical trials by molecular nature and function -- Feature summary of examples of anti-COVID-19 drug candidates in clinical trials -- Perspectives -- Annex -- Data sources and methods -- Tables of vaccine types and candidates currently in clinical trials -- Examples of partial, early disclosure observed at the Israeli, U.K. and Singapore patent offices -- Glossary -- References -- Further reading. |
| Record Nr. | UNINA-9910813504403321 |
|
Staff World Intellectual Property Organization
|
||
| Geneva : , : World Intellectual Property Organization, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Global biopiracy [[electronic resource] ] : patents, plants and indigenous knowledge / / Ikechi Mgbeoji
| Global biopiracy [[electronic resource] ] : patents, plants and indigenous knowledge / / Ikechi Mgbeoji |
| Autore | Mgbeoji Ikechi <1968-> |
| Pubbl/distr/stampa | Vancouver, : UBC Press, c2006 |
| Descrizione fisica | xvi, 311 p. ; ; 24 cm |
| Disciplina | 346.04/86 |
| Collana | Law and society series |
| Soggetto topico |
Patents (International law)
Plants, Cultivated Traditional ecological knowledge Plant biotechnology Eurocentrism Biodiversity |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-282-74079-2
9786612740794 0-7748-5170-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910450174403321 |
|
Mgbeoji Ikechi <1968->
|
||
| Vancouver, : UBC Press, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Global biopiracy [[electronic resource] ] : patents, plants and Indigenous knowledge / / Ikechi Mgbeoji
| Global biopiracy [[electronic resource] ] : patents, plants and Indigenous knowledge / / Ikechi Mgbeoji |
| Autore | Mgbeoji Ikechi <1968-> |
| Pubbl/distr/stampa | Vancouver, : UBC Press, c2006 |
| Descrizione fisica | xvi, 311 p. ; ; 24 cm |
| Disciplina | 346.04/86 |
| Collana | Law and society series |
| Soggetto topico |
Patents (International law)
Plants, Cultivated Traditional ecological knowledge Plant biotechnology Eurocentrism Biodiversity |
| ISBN |
1-282-74079-2
9786612740794 0-7748-5170-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Front Matter -- Contents -- Foreword -- Preface -- Acknowledgments -- Acronyms -- Introduction -- Patents, Indigenous and Traditional Knowledge, and Biopiracy -- Implications of Biopiracy for Biological and Cultural Diversity -- The Appropriative Aspects of Biopiracy -- Patent Regimes and Biopiracy -- Conclusion -- Notes -- Selected Bibliography -- Index -- Law and Society |
| Record Nr. | UNINA-9910783748203321 |
|
Mgbeoji Ikechi <1968->
|
||
| Vancouver, : UBC Press, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Global biopiracy [[electronic resource] ] : patents, plants and Indigenous knowledge / / Ikechi Mgbeoji
| Global biopiracy [[electronic resource] ] : patents, plants and Indigenous knowledge / / Ikechi Mgbeoji |
| Autore | Mgbeoji Ikechi <1968-> |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Vancouver, : UBC Press, c2006 |
| Descrizione fisica | xvi, 311 p. ; ; 24 cm |
| Disciplina | 346.04/86 |
| Collana | Law and society series |
| Soggetto topico |
Patents (International law)
Plants, Cultivated Traditional ecological knowledge Plant biotechnology Eurocentrism Biodiversity |
| ISBN |
1-282-74079-2
9786612740794 0-7748-5170-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Front Matter -- Contents -- Foreword -- Preface -- Acknowledgments -- Acronyms -- Introduction -- Patents, Indigenous and Traditional Knowledge, and Biopiracy -- Implications of Biopiracy for Biological and Cultural Diversity -- The Appropriative Aspects of Biopiracy -- Patent Regimes and Biopiracy -- Conclusion -- Notes -- Selected Bibliography -- Index -- Law and Society |
| Record Nr. | UNINA-9910810819003321 |
|
Mgbeoji Ikechi <1968->
|
||
| Vancouver, : UBC Press, c2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Implementation of the Leahy-Smith America Invents Act [[electronic resource] ] : hearing before the Committee on the Judiciary, House of Representatives, One Hundred Twelfth Congress, second session, May 16, 2012
| Implementation of the Leahy-Smith America Invents Act [[electronic resource] ] : hearing before the Committee on the Judiciary, House of Representatives, One Hundred Twelfth Congress, second session, May 16, 2012 |
| Pubbl/distr/stampa | Washington : , : U.S. G.P.O., , 2012 |
| Descrizione fisica | 1 online resource (iv, 244 pages) : illustrations |
| Soggetto topico |
Patent laws and legislation - United States
Patent practice - United States Patents (International law) |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Implementation of the Leahy-Smith America Invents Act |
| Record Nr. | UNINA-9910702257103321 |
| Washington : , : U.S. G.P.O., , 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Incentives for global public health : patent law and access to essential medicines / / edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein [[electronic resource]]
| Incentives for global public health : patent law and access to essential medicines / / edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein [[electronic resource]] |
| Pubbl/distr/stampa | Cambridge : , : Cambridge University Press, , 2010 |
| Descrizione fisica | 1 online resource (xxi, 512 pages) : digital, PDF file(s) |
| Disciplina | 362.17/82 |
| Collana | Connecting international law with public law |
| Soggetto topico |
Pharmaceutical policy
Patent laws and legislation Drugs - Patents Patents (International law) |
| ISBN |
0-511-85021-2
1-107-20320-1 1-282-72332-4 9786612723322 0-511-74929-5 0-511-74349-1 0-511-75004-8 0-511-74242-8 0-511-75078-1 0-511-74458-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction: access to essential medicines: public health and international law / Thomas Pogge, Matthew Rimmer and Kim Rubenstein -- TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis / Rochelle C. Dreyfuss -- The TRIPS waiver as a recognition of public health concerns in the WTO / Andrew D. Mitchell and Tania Voon -- Public law challenges to the regulation of pharmaceutical patents in the US bilateral free trade agreements / Hitoshi Nasu -- Global health and development: patents and public interest / Elizabeth Siew Kuan Ng -- The Health Impact Fund: better pharmaceutical innovations at much lower price / Thomas Pogge -- The Health Impact Fund: a critique / Kathleen Liddell -- A prize system as a partial solution to the health crisis in the developing world / William W. Fisher and Talha Syed -- Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation / Thomas Faunce -- Opening the dam: patent pools, innovation, and access to essential medicines / Dianne Nicol and Jane Nielsen -- Open source drug discovery: a revolutionary paradigm or a Utopian model? Krishna Ravi Srinivas -- Accessing and benefit sharing avian influenza viruses through the World Health Organisation: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? / Charles Lawson and Barbara Ann Hocking -- The Lazarus effect: the (RED) campaign and creative capitalism / Matthew Rimmer -- Beyond TRIPS: the role of non-state actors and access to essential medicines / Noah Benjamin Novogrodsky -- Securing health through rights / Katharine G. Young -- The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India / Rajshree Chandra -- Tipping point: Thai compulsory licenses redefine essential medicines debate / Jonathan Burton-MacLeod. |
| Record Nr. | UNINA-9910459296403321 |
| Cambridge : , : Cambridge University Press, , 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Incentives for global public health : patent law and access to essential medicines / / edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein [[electronic resource]]
| Incentives for global public health : patent law and access to essential medicines / / edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein [[electronic resource]] |
| Pubbl/distr/stampa | Cambridge : , : Cambridge University Press, , 2010 |
| Descrizione fisica | 1 online resource (xxi, 512 pages) : digital, PDF file(s) |
| Disciplina | 362.17/82 |
| Collana | Connecting international law with public law |
| Soggetto topico |
Pharmaceutical policy
Patent laws and legislation Drugs - Patents Patents (International law) |
| ISBN |
0-511-85021-2
1-107-20320-1 1-282-72332-4 9786612723322 0-511-74929-5 0-511-74349-1 0-511-75004-8 0-511-74242-8 0-511-75078-1 0-511-74458-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction: access to essential medicines: public health and international law / Thomas Pogge, Matthew Rimmer and Kim Rubenstein -- TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis / Rochelle C. Dreyfuss -- The TRIPS waiver as a recognition of public health concerns in the WTO / Andrew D. Mitchell and Tania Voon -- Public law challenges to the regulation of pharmaceutical patents in the US bilateral free trade agreements / Hitoshi Nasu -- Global health and development: patents and public interest / Elizabeth Siew Kuan Ng -- The Health Impact Fund: better pharmaceutical innovations at much lower price / Thomas Pogge -- The Health Impact Fund: a critique / Kathleen Liddell -- A prize system as a partial solution to the health crisis in the developing world / William W. Fisher and Talha Syed -- Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation / Thomas Faunce -- Opening the dam: patent pools, innovation, and access to essential medicines / Dianne Nicol and Jane Nielsen -- Open source drug discovery: a revolutionary paradigm or a Utopian model? Krishna Ravi Srinivas -- Accessing and benefit sharing avian influenza viruses through the World Health Organisation: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? / Charles Lawson and Barbara Ann Hocking -- The Lazarus effect: the (RED) campaign and creative capitalism / Matthew Rimmer -- Beyond TRIPS: the role of non-state actors and access to essential medicines / Noah Benjamin Novogrodsky -- Securing health through rights / Katharine G. Young -- The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India / Rajshree Chandra -- Tipping point: Thai compulsory licenses redefine essential medicines debate / Jonathan Burton-MacLeod. |
| Record Nr. | UNINA-9910784943703321 |
| Cambridge : , : Cambridge University Press, , 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Incentives for global public health : patent law and access to essential medicines / / edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein [[electronic resource]]
| Incentives for global public health : patent law and access to essential medicines / / edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein [[electronic resource]] |
| Pubbl/distr/stampa | Cambridge : , : Cambridge University Press, , 2010 |
| Descrizione fisica | 1 online resource (xxi, 512 pages) : digital, PDF file(s) |
| Disciplina | 362.17/82 |
| Collana | Connecting international law with public law |
| Soggetto topico |
Pharmaceutical policy
Patent laws and legislation Drugs - Patents Patents (International law) |
| ISBN |
0-511-85021-2
1-107-20320-1 1-282-72332-4 9786612723322 0-511-74929-5 0-511-74349-1 0-511-75004-8 0-511-74242-8 0-511-75078-1 0-511-74458-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction: access to essential medicines: public health and international law / Thomas Pogge, Matthew Rimmer and Kim Rubenstein -- TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis / Rochelle C. Dreyfuss -- The TRIPS waiver as a recognition of public health concerns in the WTO / Andrew D. Mitchell and Tania Voon -- Public law challenges to the regulation of pharmaceutical patents in the US bilateral free trade agreements / Hitoshi Nasu -- Global health and development: patents and public interest / Elizabeth Siew Kuan Ng -- The Health Impact Fund: better pharmaceutical innovations at much lower price / Thomas Pogge -- The Health Impact Fund: a critique / Kathleen Liddell -- A prize system as a partial solution to the health crisis in the developing world / William W. Fisher and Talha Syed -- Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation / Thomas Faunce -- Opening the dam: patent pools, innovation, and access to essential medicines / Dianne Nicol and Jane Nielsen -- Open source drug discovery: a revolutionary paradigm or a Utopian model? Krishna Ravi Srinivas -- Accessing and benefit sharing avian influenza viruses through the World Health Organisation: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? / Charles Lawson and Barbara Ann Hocking -- The Lazarus effect: the (RED) campaign and creative capitalism / Matthew Rimmer -- Beyond TRIPS: the role of non-state actors and access to essential medicines / Noah Benjamin Novogrodsky -- Securing health through rights / Katharine G. Young -- The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India / Rajshree Chandra -- Tipping point: Thai compulsory licenses redefine essential medicines debate / Jonathan Burton-MacLeod. |
| Record Nr. | UNINA-9910819117203321 |
| Cambridge : , : Cambridge University Press, , 2010 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
